Author's posts
Cutting Drug Costs From Billions To Millions
When an article appears touting a reimagination of drug R&D that can cut costs from billions to millions, one has to take notice.
Pharma TV Ads And R&D Funding
Nevertheless, the perception remains that extraordinary amounts of money are spent on TV ads at the expense of R&D. The data show that this isn’t the case.
The Story Behind Pfizer’s Covid-19 Vaccine – CEO Bourla’s ‘Moonshot’
For those who followed every step of the race to find a vaccine to end the Covid-19 pandemic, you might think that there wasn’t much more to learn. However, there is much to be gained by reading Albert Bourla’s account of Pfizer’s efforts to do what se…
What’s Really Driving Drug Costs?
Despite the wonders accomplished by the biopharmaceutical industry in providing us vaccines and therapeutants to get us out of the coronavirus pandemic, this industry – perhaps the most important in the U.S. – continues to be under attack for the cost …
U.S. Will Not Be Paying More Than Other Wealthy Countries For Pfizer’s Covid-19 Pill
At least in this one case, wealthy nations will be doing their part to pay for drugs – and that’s a nice change.
Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?
But, if successful, this drug has the potential to indeed become the PCSK9 inhibitor for the masses. It could bring Merck full circle back to the days of Mevacor and Zocor.
The Key To The Global Covid-19 Battle Is Fixing “The Last Mile”
Hatchett is absolutely correct when is says that the focus now needs to be on “the last mile” – providing these countries with the logistical and medical resources needed to actually get these vaccines into people’s arms.
Why Are Physicians Silent About Outrageous Medical Costs?
He mainly focused on the fact that drugs cost more in the U.S. than in Europe and, as a result, Americans subsidize the costs of drugs for the rest of the world.
Volunteer For Moderna’s Covid-19 Vaccine Trial Regrets His Participation. That’s A Problem.
He is upset with Moderna’s behaviors post-approval of its Covid-19 vaccine, specifically its “ruthless corporate profit making.”
An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid
In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.
